SG11201911936YA - Substituted quinolinycyclohexylpropanamide compounds and improved methods for their preparation - Google Patents
Substituted quinolinycyclohexylpropanamide compounds and improved methods for their preparationInfo
- Publication number
- SG11201911936YA SG11201911936YA SG11201911936YA SG11201911936YA SG11201911936YA SG 11201911936Y A SG11201911936Y A SG 11201911936YA SG 11201911936Y A SG11201911936Y A SG 11201911936YA SG 11201911936Y A SG11201911936Y A SG 11201911936YA SG 11201911936Y A SG11201911936Y A SG 11201911936YA
- Authority
- SG
- Singapore
- Prior art keywords
- quinolinycyclohexylpropanamide
- substituted
- compounds
- preparation
- improved methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762527835P | 2017-06-30 | 2017-06-30 | |
| US201762527821P | 2017-06-30 | 2017-06-30 | |
| US201862649155P | 2018-03-28 | 2018-03-28 | |
| PCT/US2018/040276 WO2019006292A1 (fr) | 2017-06-30 | 2018-06-29 | Composés quinolinycyclohexylpropanamide substitués et procédés améliorés pour leur préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201911936YA true SG11201911936YA (en) | 2020-01-30 |
Family
ID=64741905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201911936YA SG11201911936YA (en) | 2017-06-30 | 2018-06-29 | Substituted quinolinycyclohexylpropanamide compounds and improved methods for their preparation |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11236048B2 (fr) |
| EP (1) | EP3645008A4 (fr) |
| JP (1) | JP7315483B2 (fr) |
| KR (1) | KR20200024252A (fr) |
| CN (1) | CN111655264B (fr) |
| AU (1) | AU2018291021B2 (fr) |
| BR (1) | BR112019027156A2 (fr) |
| CA (1) | CA3066260A1 (fr) |
| IL (1) | IL271233B (fr) |
| MX (1) | MX2019014861A (fr) |
| SG (1) | SG11201911936YA (fr) |
| WO (1) | WO2019006292A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3644993B1 (fr) | 2017-06-30 | 2023-08-02 | Bristol-Myers Squibb Company | Formes amorphes et cristallines d'inhibiteurs de l'ido |
| CN110357813A (zh) * | 2018-04-09 | 2019-10-22 | 信达生物制药(苏州)有限公司 | 一种新型吲哚胺2,3-双加氧酶抑制剂及其制备方法和用途 |
| CN115151306A (zh) * | 2019-11-26 | 2022-10-04 | 百时美施贵宝公司 | (r)-n-(4-氯苯基)-2-((1s，4s)-4-(6-氟喹啉-4-基)环己基)丙酰胺的盐/共晶 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53149910A (en) * | 1977-06-02 | 1978-12-27 | Sagami Chem Res Center | Preparation of 1,3-dicarbonyl compound derivatives |
| JPS6034940B2 (ja) * | 1980-11-13 | 1985-08-12 | ダイキン工業株式会社 | フルオロマロン酸誘導体およびその製法 |
| US6133472A (en) * | 1998-01-20 | 2000-10-17 | Alliedsignal Inc. | Fluorinated oxyvinyl compounds and methods of preparing and using same |
| US20010041700A1 (en) * | 1999-07-30 | 2001-11-15 | Younes Bekkali | Novel succinate derivative compounds useful as cysteine protease inhibitors |
| US20040171614A1 (en) | 2002-02-06 | 2004-09-02 | Schering-Plough Corporation | Novel gamma secretase inhibitors |
| JP4888766B2 (ja) | 2006-07-11 | 2012-02-29 | 日東電工株式会社 | 多官能化合物の製造方法 |
| JP4936048B2 (ja) * | 2006-07-11 | 2012-05-23 | 日東電工株式会社 | 多官能化合物、光記録材料、光記録媒体、光記録再生装置、光導波路材料、および光配向膜材料 |
| CN103333157A (zh) | 2008-09-02 | 2013-10-02 | 诺瓦提斯公司 | 作为激酶抑制剂的吡啶甲酰胺衍生物 |
| WO2012050159A1 (fr) | 2010-10-14 | 2012-04-19 | 田辺三菱製薬株式会社 | Dérivé d'amide et son utilisation |
| MX355480B (es) | 2013-11-01 | 2018-04-19 | Novartis Ag | Amino-heteroaril-benzamidas como inhibidores de cinasa. |
| NZ726513A (en) * | 2014-05-28 | 2023-07-28 | Memorial Sloan Kettering Cancer Center | Anti-gitr antibodies and methods of use thereof |
| UY36390A (es) * | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
| AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
| US20190282714A1 (en) | 2016-07-19 | 2019-09-19 | Bristol-Myers Squibb Company | Radioligands for imaging the ido1 enzyme |
| CN109843293A (zh) * | 2016-08-26 | 2019-06-04 | 百时美施贵宝公司 | 吲哚胺2,3-双加氧酶的抑制剂及其使用方法 |
| EP3644993B1 (fr) | 2017-06-30 | 2023-08-02 | Bristol-Myers Squibb Company | Formes amorphes et cristallines d'inhibiteurs de l'ido |
-
2018
- 2018-06-29 IL IL271233A patent/IL271233B/en unknown
- 2018-06-29 CA CA3066260A patent/CA3066260A1/fr active Pending
- 2018-06-29 SG SG11201911936YA patent/SG11201911936YA/en unknown
- 2018-06-29 EP EP18825396.7A patent/EP3645008A4/fr active Pending
- 2018-06-29 JP JP2019572564A patent/JP7315483B2/ja active Active
- 2018-06-29 MX MX2019014861A patent/MX2019014861A/es unknown
- 2018-06-29 US US16/624,448 patent/US11236048B2/en active Active
- 2018-06-29 CN CN201880044020.5A patent/CN111655264B/zh active Active
- 2018-06-29 WO PCT/US2018/040276 patent/WO2019006292A1/fr active Application Filing
- 2018-06-29 BR BR112019027156-2A patent/BR112019027156A2/pt unknown
- 2018-06-29 AU AU2018291021A patent/AU2018291021B2/en active Active
- 2018-06-29 KR KR1020207002488A patent/KR20200024252A/ko active IP Right Grant
-
2021
- 2021-11-12 US US17/524,789 patent/US20220127233A1/en not_active Abandoned
- 2021-12-16 US US17/552,929 patent/US11919863B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019027156A2 (pt) | 2020-06-30 |
| IL271233A (en) | 2020-01-30 |
| US20200123109A1 (en) | 2020-04-23 |
| CN111655264A (zh) | 2020-09-11 |
| AU2018291021B2 (en) | 2022-07-28 |
| JP7315483B2 (ja) | 2023-07-26 |
| WO2019006292A1 (fr) | 2019-01-03 |
| US11236048B2 (en) | 2022-02-01 |
| MX2019014861A (es) | 2020-02-13 |
| US11919863B2 (en) | 2024-03-05 |
| WO2019006292A8 (fr) | 2019-12-26 |
| CA3066260A1 (fr) | 2019-01-03 |
| IL271233B (en) | 2022-09-01 |
| JP2020526504A (ja) | 2020-08-31 |
| US20220267273A1 (en) | 2022-08-25 |
| KR20200024252A (ko) | 2020-03-06 |
| CN111655264B (zh) | 2023-08-15 |
| AU2018291021A1 (en) | 2020-02-06 |
| EP3645008A4 (fr) | 2020-12-09 |
| EP3645008A1 (fr) | 2020-05-06 |
| US20220127233A1 (en) | 2022-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257295A1 (zh) | 用於免疫腫瘤學的組合物和方法 | |
| ZA201804070B (en) | Eif4-a-inhibiting compounds and methods related thereto | |
| HK1249758A1 (zh) | 抗微生物化合物及其製備和使用方法 | |
| IL264258B (en) | Diazahetero-bicyclic substituted compounds and their use | |
| IL254132A0 (en) | Solid preparation | |
| PT3552017T (pt) | Compostos úteis como inibidores de ripk1 | |
| HK1256356A1 (zh) | 用於誘導組織形成的化合物及其用途 | |
| GB201608779D0 (en) | Methods and compounds | |
| HK1246193A1 (zh) | 用於改善認知的方法和組合物 | |
| GB201608776D0 (en) | Methods and compounds | |
| HK1256358A1 (zh) | 用於誘導組織形成的化合物及其用途 | |
| IL271233A (en) | Quinolinicyclohexylpropanamide-modified compounds and improved methods for their preparation | |
| GB201703036D0 (en) | Methods | |
| ZA201807512B (en) | Trigonelline based compounds | |
| IL260070B (en) | A method for the preparation of converted 2-aryl-ethanols | |
| DK3615520T3 (en) | Methods | |
| IL286670B (en) | Compounds for inducing tissue formation and their uses | |
| GB201719043D0 (en) | Methods and compounds | |
| HK1256243A1 (zh) | 誘導組織形成的化合物及其應用 | |
| ZA201805215B (en) | Preparation for nasal-nasopharyngeal treatment | |
| SG11202000935SA (en) | Cis-polycycloolefins and methods for forming cis-polycycloolefins | |
| IL258458B (en) | Peroxyhemiacetal profragrant and proflavor compounds | |
| GB201617146D0 (en) | Flavor composition | |
| TWI562978B (en) | Method for preparation of 1,4-cyclohexanedialkanol | |
| GB201515478D0 (en) | Dairy powder |